Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
Oral BG-12 in multiple sclerosis.
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions.
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Available evidence and outcome of off-label use of rituximab in clinical practice.
Cognitive functioning in pediatric transverse myelitis.
Myeloid cells as target of fingolimod action in multiple sclerosis.
Environmental factors acting during development to influence MS risk: insights from animal studies.
M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.
Use of the PRIMUS scale to assess quality of life in a Spanish population of multiple sclerosis patients.
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.
Genetic associations with brain cortical thickness in multiple sclerosis.
Identification of a unique TGF-β-dependent molecular and functional signature in microglia.
Neurodegenerative diseases and therapeutic strategies using iron chelators.
Tumefactive demyelination presenting during bevacizumab treatment.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Mast cells on the mind: new insights and opportunities.
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
MicroRNA-145 as one negative regulator of astrogliosis.
Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.
Pages
« first
‹ previous
…
334
335
336
337
338
339
340
341
342
…
next ›
last »